Bayer’s Aspirin/Phytosterols Combination May Draw FDA Warning
This article was originally published in The Pink Sheet Daily
Executive Summary
Bayer’s combination of aspirin and cholesterol-lowering supplement has industry stakeholders asking how FDA can avoid issuing a warning.